Back

PRIME Education, Inc. (PRIME®)

  • Pulmonary Fibrosis

New Treatment Horizons in Pulmonary Fibrosis

Pulmonary fibrosis (PF), which comprises several subtypes including idiopathic PF and progressive PF, significantly impacts patients’ quality of life as a result of lung function impairment. Management of PF is challenging as treatment options have historically been limited; however, recent advances in the understanding of underlying inflammatory and fibrotic processes have prompted investigation into several novel therapeutic targets. Tune in as we dive into the evolving pharmacologic landscape for PF and discuss strategies for clinical decision-making in light of these pivotal developments. This engaging webcast is led by renowned pulmonology experts and features an overview of an interactive 3D medical animation providing scientifically accurate visual depictions of key mediators in PF pathogenesis.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.

Credit types

AAPA Category 1 Credit™Up to 0.75 creditsAMA PRA Category 1 Credit™Up to 0.75 creditsNursingUp to 0.75 creditsPharmacyUp to 0.75 credits

MOC types

No MOC

FDA REMS

No

Qualifies for MIPS

No

Pricing

Free

Reported to ACCME by the provider

  • On-demand / recorded video
  • Credit · Up to 0.75 credits
  • Commercial Support
  • Released
    Feb 9, 2026
  • Last day to claim credit
    Feb 9, 2027 4 months left